Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

A Vaccine Worth Taking

Discover the groundbreaking cholesterol conversion vaccine that may stop good cholesterol from becoming bad, as developed by Avant Immunotherapeutics.

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Like fatty foods? Worry about cholesterol? No problem, if researchers at Avant Immunotherapeutics Inc. in Needham, Massachusetts, have their way with a vaccine designed to stop the body from converting good cholesterol (HDL) into bad (LDL).

The body normally changes HDL to LDL, so Avant researchers decided that derailing that conversion would head off cholesterol problems at the pass. Using the human immune system as an ally, scientists attached a tetanus toxin to a protein necessary for HDL's transformation to LDL, and injected it into rabbits fed a high-fat diet. The immune system's assault on the targeted protein blocked the conversion. Levels of good cholesterol skyrocketed; levels of bad dropped.

The worry is that the protein might be essential to other important functions in the body. But a group of Japanese with a genetic mutation that blocks cholesterol conversion, mimicking the vaccine's effect, live well into their eighties with healthy ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles